Press Room
4th European Conference on Pharmaceutics

HOVIONE PRESENTATION
Abstract: “Recent advances in ASD formulations: Dispersome® as alternative carrier in a high-throughput screening setup”
Presenter: Ana Costa, Modelling & PAT Scientist at Hovione |
Date: Monday, March 20th, 2023 |
Session: Bioavailability, absorption enhancement and in-vitro/In-vivo correlations |
Panel number: 56 |
Contact us to learn more about Dispersome®
By increasing drug solubility, the Dispersome® platform aims at improving oral bioavailability and therapeutic outcomes for patients. Dispersome® formulations are compatible with standard pharmaceutical processes and Spray Drying provides a scalable manufacturing solution.
Dispersome® is now part of ASD-HIPROS the most advanced and accurate screening tool to identify the best Amorphous Solid Dispersion formulations by Spray Drying.
Schedule a meeting with our experts.

Find more about the 4th European Conference on Pharmaceutics.
Also in the Press Room
Hovione receives the 2023 CDMO Leadership Award in all six categories and is champion in Compatibility and Expertise
Teknoscienze, 13 March 2023
Hovione and GEA aim to increase adoption of continuous tableting
Outsourcing-Pharma, 4 January 2023